Related content

Systemic lupus erythematosus activity and depression

By Skare Thelma   da Silva Magalhães Vinicius   Siqueira Ramón  

Rheumatology International, Vol. 34, Iss. 3, 2014-03 ,pp. : 445-446

Springer Publishing Company

Access to resources Recommend Favorite

Bone Metabolism in Patients with Systemic Lupus Erythematosus: Effect of disease activity and glucocorticoid treatment

By Hansen M   Halberg P   Kollerup G   Pedersen-Zbinden B   Hørslev-Petersen K   Hyldstrup L   Lorenzen I  

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 3, 1998-08 ,pp. : 197-206

Informa Healthcare

Access to resources Recommend Favorite

The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus

By Weng Meng-Yu   Weng Chia-Tse   Liu Ming-Fei  

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 771-775

Springer Publishing Company

Access to resources Recommend Favorite

Musculoskeletal and neuropsychiatric manifestations are the main source of persisting affection and organ damage in a German population of patients with systemic lupus erythematosus

By Fiehn C.   Wilmes A.   Max R.   Willand L.   Löwe B.   Andrassy K.   Ho A. D.   Lorenz H.  

Scandinavian Journal of Rheumatology, Vol. 35, Iss. 2, 2006-04 ,pp. : 157-159

Informa Healthcare

Access to resources Recommend Favorite

Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study

By Mok C. C.   Ho L. Y.   Cheung M. Y.   Yu K. L.   To C. H.  

Scandinavian Journal of Rheumatology, Vol. 38, Iss. 2, 2009-01 ,pp. : 121-127

Informa Healthcare

Access to resources Recommend Favorite